Rebound pulmonary hypertension and cardiogenic shock after withdrawal of inhaled prostacyclin

Anesthesiology. 2004 Apr;100(4):1023-5. doi: 10.1097/00000542-200404000-00040.
No abstract available

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Inhalation
  • Aged
  • Epoprostenol / administration & dosage
  • Epoprostenol / adverse effects*
  • Humans
  • Hypertension, Pulmonary / etiology*
  • Male
  • Shock, Cardiogenic / etiology*
  • Substance Withdrawal Syndrome / etiology*

Substances

  • Epoprostenol